Cramer's 6 Stocks in 60 Seconds: CYN TEVA SKT TTWO NVS DHR (Update1)
Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".
(Updates from 11:04 a.m. ET with closing information.)
NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk On The Street" Wednesday:
Cramer thinks City National (CYN) is a classic, good bank. "You should buy it." Shares were flat at the Wednesday close.
Teva Pharmaceutical (TEVA) "has been such a dog, and it continues to be so, there's nothing special happening here," Cramer said. Shares closed down an unhealthy 5.3%.
After reading an interview in the New York Times about Tanger Factory Outlet Centers (SKT), Cramer said the company's stock has been an outperformer and noted CEO Steve Tanger talked about having a terrific holiday season. SKT was flat. Novartis (NVS) has been a decent company, Cramer said. "I wouldn't sell this stock," he advised, adding there's "no way" this company should have been downgraded. NVS closed flat. On Piper Jaffray's upgrade of Take-Two Interactive Software (TTWO), Cramer said it "does seem like there's some sweet spot for gaming all of a sudden. I hated the stock. I'm probably wrong. It's probably okay now." Shares closed up 2.6%. Danaher (DHR) reaffirmed 2012 guidance and its 2013 outlook. The big-cap stocks have been saying things are looking fine, Cramer said. "These are not supposed to look fine," Cramer said, so maybe it's a sign of better days coming. Shares closed up 2.2%. To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Anthony Buccino in New York.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV